SCHEMBL14733344

SCHEMBL14733344

Cc1ccc(N2CCN(c3ccc(Cl)cc3)C2=O)cc1N1CCN(C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.47
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 4/20 0.45
MAPT P10636 4/20 0.45
ALOX12 P18054 1/20 0.45
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RECQL P46063 1/20 0.44
PTK2B Q14289 1/20 0.44
LMNA P02545 2/20 0.44
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
KCNH2 Q12809 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
TP53 P04637 2/20 0.43
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14733342 0.88 KMT2A (0.51) POLBNPSR1ALDH1A1MAPTKDM4E
SCHEMBL2330397 0.84 HTR6 (0.56) POLBALDH1A1KDM4EGAAMAPK1
SCHEMBL19403575 0.78 ALDH1A1 (0.67) POLBNPSR1ALDH1A1MAPTLMNA
SCHEMBL14733340 0.78 DRD2 (0.43) ALDH1A1MAPTALOX12GAADRD2
SCHEMBL14733338 0.73 AR (0.47) POLBNPSR1ALDH1A1MAPTKDM4E
SCHEMBL2325995 0.72 HTR2C (0.55) DRD2DRD3MEN1KMT2AHTR1A
SCHEMBL172876 0.71 DRD2 (0.52) ALDH1A1MAPTKDM4EGAAPTK2B
SCHEMBL3791096 0.70 CYP17A1 (0.48)
SCHEMBL22349847 0.70 DRD2 (0.54) ALDH1A1MAPTALOX12DRD2DRD3
SCHEMBL2056127 0.69 GAA (0.63) POLBALDH1A1MAPTALOX12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053372-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053372-A1 5-HT RECEPTOR MODULATORS HTR1B, HTR5A, HTR1A POLB 3476/4885NPSR1 54/4885ALDH1A1 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.